Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    10811152 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation Preventive Effects of Cetylpyridinium Chloride on SarcopeniaStudy
Condition: Sarcopenia
Interventions: Drug: cetylpyridinium chloride;   Drug: Placebo
2 Completed Exercise Trial for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Behavioral: Healthy Lifestyle Program;   Behavioral: Physical Activity Intervention

Indicates status has not been verified in more than two years